Literature DB >> 17051242

Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis.

A Ledda, G Caocci, G Spinicci, E Cocco, E Mamusa, G La Nasa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17051242     DOI： 10.1038/sj.leu.2404443

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

Review 1.  Immunosuppressive agents in multiple sclerosis.

Authors:  Oliver Neuhaus; Bernd C Kieseier; Hans-Peter Hartung
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

2.  Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation.

Authors:  Marco Capobianco; Y Motuzova; J Frau; E Cocco; E Mamusa; M G Marrosu; A Bertolotto
Journal:  Neurol Sci       Date:  2011-11-25       Impact factor: 3.307

Review 3.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

Review 4.  Global characteristics of childhood acute promyelocytic leukemia.

Authors:  L Zhang; A Samad; M S Pombo-de-Oliveira; G Scelo; M T Smith; J Feusner; J L Wiemels; C Metayer
Journal:  Blood Rev       Date:  2014-09-30       Impact factor: 8.250

5.  Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis.

Authors:  Marco Capobianco; Simona Malucchi; Stefano Ulisciani; Carmen Fava; Giovanna Rege Cambrin; Luigina Avonto; Giuseppe Saglio; Antonio Bertolotto
Journal:  Neurol Sci       Date:  2008-07-09       Impact factor: 3.307

6.  Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis.

Authors:  Syed Khizer Hasan; Ashley N Mays; Tiziana Ottone; Antonio Ledda; Giorgio La Nasa; Chiara Cattaneo; Erika Borlenghi; Lorella Melillo; Enrico Montefusco; José Cervera; Christopher Stephen; Gnanam Satchi; Anne Lennard; Marta Libura; Jo Ann W Byl; Neil Osheroff; Sergio Amadori; Carolyn A Felix; Maria Teresa Voso; Wolfgang R Sperr; Jordi Esteve; Miguel A Sanz; David Grimwade; Francesco Lo-Coco
Journal:  Blood       Date:  2008-07-23       Impact factor: 22.113

7.  Comprehensive Analysis of HERV Transcriptome in HIV+ Cells: Absence of HML2 Activation and General Downregulation of Individual HERV Loci.

Authors:  Nicole Grandi; Maria Paola Pisano; Sante Scognamiglio; Eleonora Pessiu; Enzo Tramontano
Journal:  Viruses       Date:  2020-04-23       Impact factor: 5.048

8.  Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study.

Authors:  Victor M Rivera; Douglas R Jeffery; Bianca Weinstock-Guttman; Daena Bock; Fernando Dangond
Journal:  BMC Neurol       Date:  2013-07-11       Impact factor: 2.474
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.